Blast-phase Chronic Myelogenous Leukemia
1 clinical trials · Condition
◉ Watch Blast-phase Chronic Myelogenous Leukemia
| Record | Firm | Date |
|---|---|---|
| A Phase 1 Study of the HSP90 Inhibitor, STA-9090 in Subjects With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Blast-phase Chronic Myelogenous Leukemia (NCT00964873) | Synta Pharmaceuticals Corp. | 2009-08-01 |
Track Blast-phase Chronic Myelogenous Leukemia automatically
Every clearance here is in the API, with alerts when new ones post.